Assessment of Sarcopenia Using Muscle Ultrasound in Patients With Cirrhosis and Sarcopenic Obesity (AMUSE STUDY)

被引:17
|
作者
Dhariwal, Sukhpal [1 ]
Roy, Akash [1 ]
Taneja, Sunil [1 ,2 ]
Bansal, Akash [1 ]
Gorsi, Ujjwal [1 ]
Singh, Surender [1 ]
De, Arka [1 ]
Verma, Nipun [1 ]
Premkumar, Madhumita [1 ]
Duseja, Ajay [1 ]
Dhiman, Radha [1 ]
Singh, Virendra [1 ]
机构
[1] PGIMER, Dept Hepatol, Chandigarh, India
[2] Inst Med Educ & Res, Chandigarh 160012, India
关键词
cirrhosis; sarcopenia; obesity; ultrasound; LIVER; MODEL; MASS;
D O I
10.1097/MCG.0000000000001745
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims:Sarcopenic obesity (SO) marks a confluence of 2 complex entities involving the muscle-liver-adipose tissue axis. Computed tomographic (CT) scan-derived skeletal muscle index (SMI) remains the gold standard for sarcopenia assessment in SO. However, it has intrinsic limitations of cost, radiation, and point of care applicability. We assessed the role of muscle ultrasound (US) in SO. Methods:A total of 52 patients with cirrhosis and obesity were assessed for sarcopenia using SMI. US assessment of thigh and forearm muscles was done to record quadriceps muscle thickness (QMT), quadriceps feather index (QMFI), forearm muscle thickness (FMT), and forearm feather index (FFI), respectively. Evaluated US parameters were correlated with SMI and assessed for diagnostic accuracy using the area under the curve. Results:A total of 40 (76.9%) males and 12 (23.1%) females [mean age: 50.9 y (43.8 to 53.5 y)] were included. QMT [0.45 cm/m(2) (0.42 to 0.48 cm/m(2)) vs. 0.67 cm/m(2) (0.63 to 0.70 cm/m(2))], QMFI [0.82 cm/m(2) (0.77 to 0.87 cm/m(2)) vs. 1.12 cm/m(2) (1.06 to 1.19 cm/m(2))], FMT [0.19 cm/m(2) (0.17 to 0.20 cm/m(2)) vs. 0.25 cm/m(2) (0.23 to 0.27 cm/m(2))], and FFI [0.38 cm/m(2) (0.35 to 0.412 cm/m(2)) vs. 0.47 cm/m(2) (0.44 to 0.50 cm/m(2))] were significantly lower in patients with SO (P<0.01). A positive correlation with SMI was seen for all parameters in the entire cohort. The strongest correlation was exhibited by QMT (r=0.70) and QMFI (r=0.70) in males. The area under the curve of QMT, QMFI, FMT, and FFI were 0.98 (95% confidence interval: 0.96-1), 0.95 (0.89-1), 0.85 (0.75-0.96), and 0.80 (0.68-0.93), respectively. Conclusions:US-based assessment of sarcopenia has excellent diagnostic accuracy and correlates well with computed tomography-SMI in patients with SO. US may serve as an easy-to-use, point of care tool for assessing sarcopenia in SO with the advantage of repeated sequential assessment.
引用
收藏
页码:841 / 847
页数:7
相关论文
共 50 条
  • [21] Sarcopenia and sarcopenic obesity in patients with complex abdominal wall hernias
    Rinaldi, John M.
    Geletzke, Abby K.
    Phillips, Brett E.
    Miller, Jamie
    Dykes, Thomas M.
    Soybel, David I.
    AMERICAN JOURNAL OF SURGERY, 2016, 212 (05): : 903 - 911
  • [22] Assessment of sarcopenic obesity in patients with acromegaly
    Rocha, Claudia Pinheiro Sanches
    Hupalowski, Natalia Nachbar
    Andrade, Vicente Florentino Castaldo
    Boguszewski, Cesar Luiz
    Borba, Victoria Zeghbi Cochenski
    PITUITARY, 2025, 28 (01)
  • [23] Impact of sarcopenia, obesity, and sarcopenic obesity on the metabolic profile in heart failure patients
    De La Concha Duarte, M. Mildred Corina
    Orea-Tejeda, A.
    Sanchez-Santillan, R.
    Gonzalez-Islas, D.
    Rodriguez-Medina, A.
    Hernandez-Lopez, N.
    Galvan-Bautista, G.
    Carranza-Munoz, P.
    Dominguez-Moya, D.
    Jimenez-Gallardo, L.
    Jimenez-Valentin, A.
    Perez-Garcia, I.
    Galicia-Amor, S.
    Ballesteros-Vazquez, O.
    Camacho-Mendoza, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 317 - 317
  • [24] Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick, Toine M.
    van Nijnatten, Thiemo J. A.
    van Dam, Ronald M.
    van Mierlo, Kim
    Dello, Simon A. W. G.
    Neumann, Ulf P.
    Damink, Steven W. M. Olde
    Dejong, Cornelis H. C.
    HPB, 2015, 17 (05) : 438 - 446
  • [25] SARCOPENIA, OBESITY AND SARCOPENIC OBESITY IN LIVER TRANSPLANTATION: A BODY COMPOSITION PROSPECTIVE STUDY
    Anastacio, Lucilene Rezende
    Ferreira, Livia Garcia
    Ribeiro, Helem Sena
    Dias Diniz, Kiara Goncalves
    Lima, Agnaldo Soares
    Correia, Maria Isabel T. D.
    Vilela, Eduardo Garcia
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2019, 32 (02):
  • [26] Multidimensional Assessment of Sarcopenia and Sarcopenic Obesity in Geriatric Patients: Creatinine/Cystatin C Ratio Performs Better than Sarcopenia Index
    Khalil, Mohamad
    Di Ciaula, Agostino
    Jaber, Nour
    Grandolfo, Roberta
    Fiermonte, Flavia
    Portincasa, Piero
    METABOLITES, 2024, 14 (06)
  • [27] Assessment of sarcopenia and outcome with ultrasound-based measurements in patients with liver cirrhosis
    Flagiello, V.
    Gallo, P.
    De Vincentis, A.
    Tavaglione, F.
    Terracciani, F.
    Di Pasquale, G.
    Picardi, A.
    Gentilucci, U. Vespasiani
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S71 - S72
  • [28] Sarcopenia and sarcopenic obesity: Their association with postoperative outcomes in patients with hip fractures
    Veizi, Betul Gulsum Yavuz
    Imeri, Valbona
    Naldoven, Omer Faruk
    Guven, Sahan
    JOURNAL OF HOSPITAL MEDICINE, 2025,
  • [29] GERIATRIC STUDY IN MUNICIPALITY OF FATIH: SARCOPENIA AND SARCOPENIC OBESITY IN ELDERLY PATIENTS ACCORDING TO DIFFERENT INDEXE
    Yilmaz, O. Y.
    Kilic, C. K.
    Ozturk, G. B. O. Bahat
    Avci, S. A.
    Akcan, T. A.
    Medik, Y. M.
    Karan, M. A. K.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S558 - S559
  • [30] Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
    Montano-Loza, Aldo J.
    Angulo, Paul
    Meza-Junco, Judith
    Prado, Carla M. M.
    Sawyer, Michael B.
    Beaumont, Crystal
    Esfandiari, Nina
    Ma, Mang
    Baracos, Vickie E.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2016, 7 (02) : 126 - 135